[1] |
SMOLEN J S, ALETAHA D, BARTON A, et al. Rheumatoid arthritis[J]. Nature Reviews Disease Primers, 2018, 4: 18001. DOI:10.1038/nrdp.2018.1 |
|
[2] |
FIRESTEIN G S. Evolving concepts of rheumatoid arthritis[J]. Nature, 2003, 423(6937): 356-361. DOI:10.1038/nature01661 |
|
[3] |
韩宇飞, 高明利, 刘东武. 类风湿性关节炎的发病机制研究进展综述[J]. 中国卫生标准管理, 2021, 12(1): 162-165. HAN Y F, GAO M L, LIU D W. Review on the pathogenesis of rheumatoid arthritis[J]. China Health Standard Manage-ment, 2021, 12(1): 162-165. DOI:10.3969/j.issn.1674-9316.2021.01.061 |
|
[4] |
古结乃特汗·拜克里木, 巴燕·艾克海提, 卫荣. 类风湿性关节炎活动期中医证型与免疫学指标相关性[J]. 中医学报, 2017, 32(8): 1551-1554. GUJIENAITEHAN B K L M, BAYAN A K H T, WEI R. Cor-relation study between TCM syndrome types and laboratory indexes in active stage of rheumatoid arthritis[J]. Acta Chi-nese Medicine, 2017, 32(8): 1551-1554. |
|
[5] |
SOLOMON J J, BROWN K K. Rheumatoid arthritis-associ-ated interstitial lung disease[J]. Open Access Rheumatology, 2012, 18(4): 21-31. |
|
[6] |
JUGE P A, LEE J S, LAU J, et al. Methotrexate and rheuma-toid arthritis associated interstitial lung disease[J]. The Euro-pean Respiratory Journal, 2021, 57(2): 2000337. DOI:10.1183/13993003.00337-2020 |
|
[7] |
TERASAKI Y, TERASAKI M, KANAZAWA S, et al. Effect of H2 treatment in a mouse model of rheumatoid arthritis-as sociated interstitial lung disease[J]. Journal of Cellular and Molecular Medicine, 2019, 23(10): 7043-7053. DOI:10.1111/jcmm.14603 |
|
[8] |
CHEN J, DOYLE T J, LIU Y L, et al. Biomarkers of rheumatoid arthritis -associated interstitial lung disease[J]. Arthritis & Rheumatology (Hoboken, N J), 2015, 67(1): 28-38. |
|
[9] |
章平衡. 基于FAK/Calpain通路探讨新风胶囊抑制血小板活化改善类风湿关节炎肺功能机制[D]. 合肥: 安徽中医药大学, 2019. ZHANG P H. Mechanism research of Xinfeng capsule on inhibiting platelet activation to improve pulmonary function in rheumatoid arthritis based on FAK/calpain pathway[D]. Hefei: Anhui University of Chinese Medicine, 2019.
|
|
[10] |
HYLDGAARD C, HILBERG O, PEDERSEN A B, et al. A population-based cohort study of rheumatoid arthritis-asso-ciated interstitial lung disease: Comorbidity and mortality[J]. Annals of the Rheumatic Diseases, 2017, 76(10): 1700-1706. DOI:10.1136/annrheumdis-2017-211138 |
|
[11] |
CAVAGNA L, MONTI S, GROSSO V, et al. The multifaceted aspects of interstitial lung disease in rheumatoid arthritis[J]. Bio Med Research International, 2013, 2013(5): 759760. |
|
[12] |
AMIGUES I, RAMADURAI D, SWIGRIS J J. Current per-spectives on emerging biomarkers for rheumatoid arthritis-associated interstitial lung disease[J]. Open Access Rheu-matology: Research and Reviews, 2019, 11(2): 229-235. |
|
[13] |
VADILLO C, NIETO M A, ROMERO-BUENO F, et al. Com-ment on: Efficacy of rituximab in slowing down progression of rheumatoid arthritis-related interstitial lung disease: Data from the NEREA Registry[J]. Rheumatology, 2020, 59(8): 2099-2108. DOI:10.1093/rheumatology/kez673 |
|
[14] |
IQBAL K, KELLY C. Treatment of rheumatoid arthritis-as-sociated interstitial lung disease: A perspective review[J]. Therapeutic Advances in Musculoskeletal Disease, 2015, 7(6): 247-267. DOI:10.1177/1759720X15612250 |
|
[15] |
KRONZER V L, HUANG W X, DELLARIPA P F, et al. Lifestyle and clinical risk factors for incident rheumatoid arthritis-associated interstitial lung disease[J]. The Journal of Rheumatology, 2021, 48(5): 656-663. DOI:10.3899/jrheum.200863 |
|
[16] |
KELLY C A, SARAVANAN V, NISAR M, et al. Rheuma-toid arthritis-related interstitial lung disease: Associations, prognostic factors and physiological and radiological char-acteristics-a large multicentre UK study[J]. Rheumatology, 2014, 53(9): 1676-1682. DOI:10.1093/rheumatology/keu165 |
|
[17] |
杨金良, 任占芬, 罗寰, 等. 类风湿关节炎合并肺间质性病变的临床特点及与抗环瓜氨酸肽抗体的相关性研究[J]. 临床肺科杂志, 2020, 25(7): 1062-1065. YANG J L, REN Z F, LUO H, et al. Clinical characteristics of rheumatoid arthritis with pulmonary interstitial lesions and its correlation with anti-cyclic citrullinated peptide anti-bodies[J]. Journal of Clinical Pulmonary Medicine, 2020, 25(7): 1062-1065. DOI:10.3969/j.issn.1009-6663.2020.07.020 |
|
[18] |
KODURI G, NORTON S, YOUNG A, et al. Interstitial lung disease has a poor prognosis in rheumatoid arthritis: Results from an inception cohort[J]. Rheumatology, 2010, 49(8): 1483-1489. DOI:10.1093/rheumatology/keq035 |
|
[19] |
ZHANG Y F, LI H B, WU N W, et al. Retrospective study of the clinical characteristics and risk factors of rheumatoid arthritis-associated interstitial lung disease[J]. Clinical Rheu-matology, 2017, 36(4): 817-823. DOI:10.1007/s10067-017-3561-5 |
|
[20] |
MCFARLANE I M, ZHAZ S Y, BHAMRA M S, et al. Asse-ssment of interstitial lung disease among black rheumatoid arthritis patients[J]. Clinical Rheumatology, 2019, 38(12): 3413-3424. DOI:10.1007/s10067-019-04760-6 |
|
[21] |
NEWTON C A, OLDHAM J M, LEY B, et al. Telomere length and genetic variant associations with interstitial lung disease progression and survival[J]. The European Respiratory Jour-nal, 2019, 53(4): 1801641. DOI:10.1183/13993003.01641-2018 |
|
[22] |
JUGE P A, BORIE R, KANNENGIESSER C, et al. Shared genetic predisposition in rheumatoid arthritis-interstitial lung disease and familial pulmonary fibrosis[J]. The Euro-pean Respiratory Journal, 2017, 49(5): 1602314. DOI:10.1183/13993003.02314-2016 |
|
[23] |
赵智明. PAD酶参与CIA小鼠肺损伤诱发类风湿关节炎的可能机制及青藤碱的作用[D]. 南京: 南京中医药大学, 2018. ZHAO Z M. The possible mechanism of PAD enzyme in rheumatoid arthritis induced by lung injury in CIA mice and the effect of sinomenine[D]. Nanjing: Nanjing University of Chinese Medicine, 2018.
|
|
[24] |
MAKRYGIANNAKIS D, HERMANSSON M, ULFGREN A K, et al. Smoking increases peptidylarginine deiminase 2 enzyme expression in human lungs and increases citrullina-tion in BAL cells[J]. Annals of the Rheumatic Diseases, 2008, 67(10): 1488-1492. DOI:10.1136/ard.2007.075192 |
|
[25] |
SAMARA K D, TRACHALAKI A, TSITOURA E, et al. Upregulation of citrullination pathway: from autoimmune to idiopathic lung fibrosis[J]. Respiratory Research, 2017, 18(1): 218. DOI:10.1186/s12931-017-0692-9 |
|
[26] |
FARQUHAR H, VASSALLO R, EDWARDS A L, et al. Pul-monary complications of rheumatoid arthritis[J]. Seminars in Respiratory and Critical Care Medicine, 2019, 40(2): 194-207. DOI:10.1055/s-0039-1683995 |
|
[27] |
GILES J T, DANOFF S K, SOKOLOVE J, et al. Association of fine specificity and repertoire expansion of anticitrulli-nated peptide antibodies with rheumatoid arthritis associat-ed interstitial lung disease[J]. Annals of the Rheumatic Dis-eases, 2014, 73(8): 1487-1494. DOI:10.1136/annrheumdis-2012-203160 |
|
[28] |
JOSHUA V, HENSVOLD A H, REYNISDOTTIR G, et al. Association between number and type of different ACPA fine specificities with lung abnormalities in early, untreated rheumatoid arthritis[J]. RMD Open, 2020, 6(2): e001278. DOI:10.1136/rmdopen-2020-001278 |
|
[29] |
SHIMIZU T, NAGAFUCHI Y, HARADA H, et al. Decreased peripheral blood memory B cells are associated with the presence of interstitial lung disease in rheumatoid arthritis: A case-control study[J]. Modern Rheumatology, 2021, 31(1): 127-132. DOI:10.1080/14397595.2020.1719596 |
|
[30] |
ATKINS S R, TURESSON C, MYERS J L, et al. Morphologic and quantitative assessment of CD20 + B cell infiltrates in rheumatoid arthritis-associated nonspecific interstitial pneu-monia and usual interstitial pneumonia[J]. Arthritis and Rheumatism, 2006, 54(2): 635-641. DOI:10.1002/art.21758 |
|
[31] |
LAI N L, JIA W, WANG X, et al. Risk factors and changes of peripheral NK and T cells in pulmonary interstitial fibrosis of patients with rheumatoid arthritis[J]. Canadian Respiratory Journal, 2019, 2019: 7262065. |
|
[32] |
TURESSON C, MATTESON E L, COLBY T V, et al. In-creased CD4+ T cell infiltrates in rheumatoid arthritis-asso-ciated interstitial pneumonitis compared with idiopathic in-terstitial pneumonitis[J]. Arthritis and Rheumatism, 2005, 52(1): 73-79. DOI:10.1002/art.20765 |
|
[33] |
ANTIN-OZERKIS D, EVANS J, RUBINOWITZ A, et al. Pulmonary manifestations of rheumatoid arthritis[J]. Clin Chest Med, 2010, 31(3): 451-478. DOI:10.1016/j.ccm.2010.04.003 |
|
[34] |
沈洲立, 唐小蓉, 沈思辰, 等. 类风湿关节炎合并间质性肺疾病相关生物标志物的研究进展[J]. 医学综述, 2020, 26(13): 2507-2512. SHEN Z L, TANG X R, SHEN S C, et al. Research ad-vances of related biological markers on rheumatoid arthritis with interstitial lung disease[J]. Medical Recapitulate, 2020, 26(13): 2507-2512. DOI:10.3969/j.issn.1006-2084.2020.13.003 |
|
[35] |
O'DWYER D N, ARMSTRONG M E, COOKE G, et al. rheumatoid arthritis associated interstitial lung disease[J]. European Journal of Internal Medicine, 2013, 24(7): 597-603. DOI:10.1016/j.ejim.2013.07.004 |
|
[36] |
KIM H C, CHOI K H, JACOB J, et al. Prognostic role of blood KL-6 in rheumatoid arthritis-associated interstitial lung disease[J]. PLoS One, 2020, 15(3): e0229997. DOI:10.1371/journal.pone.0229997 |
|
[37] |
JOHNSON C. Recent advances in the pathogenesis, predic-tion, and management of rheumatoid arthritis-associated in-terstitial lung disease[J]. Current Opinion in Rheumatology, 2017, 29(3): 254-259. DOI:10.1097/BOR.0000000000000380 |
|
[38] |
SOLOMON J J, CHUNG J H, COSGROVE G P, et al. Pre-dictors of mortality in rheumatoid arthritis-associated inter-stitial lung disease[J]. The European Respiratory Journal, 2016, 47(2): 588-596. DOI:10.1183/13993003.00357-2015 |
|
[39] |
GAUHAR U A, GAFFO A L, ALARCON G S. Pulmonary manifestations of rheumatoid arthritis[J]. Semin Respir Crit Care Med, 2007, 28(4): 430-440. DOI:10.1055/s-2007-985664 |
|
[40] |
DOYLE T J, PATEL A S, HATABU H, et al. Detection of rheumatoid arthritis-interstitial lung disease is enhanced by serum biomarkers[J]. American Journal of Respiratory and Critical Care Medicine, 2015, 191(12): 1403-1412. DOI:10.1164/rccm.201411-1950OC |
|
[41] |
CHO E J, PARK K J, KO D H, et al. Analytical and clinical performance of the nanopia Krebs von den Lungen 6 assay in Korean patients with interstitial lung diseases[J]. Annals of Laboratory Medicine, 2019, 39(3): 245-251. DOI:10.3343/alm.2019.39.3.245 |
|
[42] | |
|
[43] |
杨金良, 郑学军, 任占芬, 等. 血清KL-6、SP-A在类风湿关节炎合并肺间质病变患者中的表达及临床意义[J]. 重庆医学, 2020, 49(9): 1442-1445. YANG J L, ZHENG X J, REN Z F, et al. Expression and clinical significance of serum KL-6 and SP-A in patients with rheumatoid arthritis complicating interstitial lung dis-ease[J]. Chongqing Medicine, 2020, 49(9): 1442-1445. DOI:10.3969/j.issn.1671-8348.2020.09.016 |
|
[44] |
袁菱, 童德银, 沈巍, 等. 抗类风湿关节炎药物相关性肺损伤研究进展[J]. 西北药学杂志, 2018, 33(3): 425-428. YUAN L, TONG D Y, SHEN W, et al. Research progress in anti-rheumatoid arthritis drugs induced lung injury[J]. Northwest Pharmaceutical Journal, 2018, 33(3): 425-428. DOI:10.3969/j.issn.1004-2407.2018.03.034 |
|
[45] |
JU J H, KIM S I, LEE J H, et al. Risk of interstitial lung dis-ease associated with leflunomide treatment in Korean patients with rheumatoid arthritis[J]. Arthritis and Rheuma-tism, 2007, 56(6): 2094-2096. DOI:10.1002/art.22666 |
|
[46] |
CHIKURA B, LANE S, DAWSON J K. Clinical expression of leflunomide-induced pneumonitis[J]. Rheumatology, 2009, 48(9): 1065-1068. DOI:10.1093/rheumatology/kep050 |
|
[47] |
SAWADA T, INOKUMA S, SATO T, et al. Leflunomide-in-duced interstitial lung disease: prevalence and risk factors in Japanese patients with rheumatoid arthritis[J]. Rheuma-tology, 2009, 48(9): 1069-1072. DOI:10.1093/rheumatology/kep052 |
|
[48] |
NEIL M, ALASTAIR I J, MICHAEL L C, et al. Hypersensi-tivity pneumonitis associated with leflunomide therapy[J]. The Journal of Rheumatology, 2007, 34(9): 1934-1937. |
|
[49] |
BERNSTEIN E J, BARR R G, AUSTIN J H M, et al. Rheumatoid arthritis -associated autoantibodies and sub-clinical interstitial lung disease: The Multi-Ethnic Study of Atherosclerosis[J]. Thorax, 2016, 71(12): 1082-1090. DOI:10.1136/thoraxjnl-2016-208932 |
|
[50] |
HINZ B, PHAN S H, THANNICKAL V J, et al. The myofi-broblast: One function, multiple origins[J]. The American Journal of Pathology, 2007, 170(6): 1807-1816. DOI:10.2353/ajpath.2007.070112 |
|
[51] |
NAMBA T, TANAKA K I, ITO Y, et al. Induction of EMT-like phenotypes by an active metabolite of leflunomide and its contribution to pulmonary fibrosis[J]. Cell Death & Dif-ferentiation, 2010, 17(12): 1882-1895. |
|
[52] |
沈艳玲, 吴辉, 黄环, 等. CTX联合BUS对小鼠卵巢及早期肺损伤的研究[J]. 中国现代医生, 2015, 53(5): 14-16, 19, 161. SHEN Y L, WU H, HUANG H, et al. The effects of cyclophos-phamide and busulfan on ovarian injuries and early lung in-jury[J]. China Modern Doctor, 2015, 53(5): 14-16, 19, 161. |
|
[53] |
SUN Y, ITO S, NISHIO N, et al. Acrolein induced both pul-monary inflammation and the death of lung epithelial cells[J]. Toxicology Letters, 2014, 229(2): 384-392. DOI:10.1016/j.toxlet.2014.06.021 |
|
[54] |
EL-EMAM S Z. Sesamol alleviates the cytotoxic effect of cyclophosphamide on normal human lung WI-38 cells via suppressing RAGE/NF-κB/autophagy signaling[J]. Natural Products and Bioprospecting, 2021, 11(3): 333-343. DOI:10.1007/s13659-020-00286-6 |
|
[55] |
KAWASHIRI S Y, KAWAKAMI A, SAKAMOTO N, et al. A fatal case of acute exacerbation of interstitial lung disease in a patient with rheumatoid arthritis during treatment with tocilizumab[J]. Rheumatology International, 2012, 32(12): 4023-4026. DOI:10.1007/s00296-010-1525-z |
|
[56] |
HUANG Y, LIN W, CHEN Z, et al. Effect of tumor necrosis factor inhibitors on interstitial lung disease in rheumatoid arthritis: Angel or demon?[J]. Drug Design, Development and Therapy, 2019, 13: 2111-2125. DOI:10.2147/DDDT.S204730 |
|
[57] |
常文静, 蔡辉. 类风湿关节炎相关间质性肺病的研究进展[J]. 现代医学, 2020, 48(8): 1093-1099. CHANG W J, CAI H. Advances in research on rheumatoid arthritis-associated interstitial lung disease[J]. Modern Med-ical Journal, 2020, 48(8): 1093-1099. DOI:10.3969/j.issn.1671-7562.2020.08.032 |
|
[58] |
尹婷婷, 顾晓燕, 冯卫忠, 等. N-乙酰半胱氨酸联合肺康复治疗对类风湿关节炎相关间质性肺病患者运动耐力及生活质量的影响[J]. 实用药物与临床, 2017, 20(3): 290-293. YIN T T, GU X Y, FENG W Z, et al. Effect of N-acetylcys-teine combined with pulmonary rehabilitation on the exer-cise endurance and quality of life of patients with rheuma-toid arthritis-interstitial lung disease[J]. Practical Pharmacy and Clinical Remedies, 2017, 20(3): 290-293. |
|
[59] |
陈皓然, 吴秋惠, 王鸯鸯, 等. 皮肌炎和多发性肌炎相关间质性肺炎的药物治疗[J]. 中南药学, 2020, 18(5): 811-815. CHEN H R, WU Q H, WANG Y Y, et al. Drug therapy of dermatomyositis/polymyositis-associated interstitial lung disease[J]. Central South Pharmacy, 2020, 18(5): 811-815. |
|
[60] |
宋周烨, 徐媛, 葛卫红, 等. 结缔组织病相关间质性肺病患者环孢素血药浓度监测与评价[J]. 中国临床药学杂志, 2019, 28(2): 110-114. SONG Z Y, XU Y, GE W H, et al. Monitoring and evalua-tion of cyclosporine blood concentration in patients with connective tissue disease -associated interstitial lung dis-ease[J]. Chinese Journal of Clinical Pharmacy, 2019, 28(2): 110-114. |
|
[61] |
李小燕, 徐亮. 类风湿关节炎合并间质性肺病研究进展[J]. 安徽医学, 2011, 32(10): 1787-1789. LI X Y, XU L. Research progress of rheumatoid arthritis complicated with interstitial lung disease[J]. Anhui Medical Journal, 2011, 32(10): 1787-1789. DOI:10.3969/j.issn.1000-0399.2011.10.055 |
|
[62] |
何欣, 黄玉琴, 青玉凤, 等. 类风湿关节炎相关性肺间质病变治疗进展[J]. 临床荟萃, 2021, 36(1): 75-79. HE X, HUANG Y Q, QING Y F, et al. Progress in the treat-ment of rheumatoid arthritis-related pulmonary interstitial lesions[J]. Clinical Focus, 2021, 36(1): 75-79. DOI:10.3969/j.issn.1004-583X.2021.01.016 |
|
[63] |
杨金良, 郑学军, 赵亚君, 等. 吡非尼酮联合糖皮质激素治疗类风湿关节炎合并肺间质纤维化的效果及对血清KL-6、ACPA的影响[J]. 广东医学, 2018, 39(23): 3552-3556. YANG J L, ZHENG X J, ZHAO Y J, et al. Clinical observa-tion of pifenidone combined with glucocorticoid in the treat-ment of rheumatoid arthritis complicated with pulmonary in-terstitial fibrosis and its effect on serum KL-6 and ACPA[J]. Guangdong Medical Journal, 2018, 39(23): 3552-3556. DOI:10.3969/j.issn.1001-9448.2018.23.025 |
|
[64] |
WOLLIN L, MAILLET I, QUESNIAUX V, et al. Antifibrotic and anti-inflammatory activity of the tyrosine kinase in-hibitor nintedanib in experimental models of lung fibrosis[J]. The Journal of Pharmacology and Experimental Therapeu-tics, 2014, 349(2): 209-220. DOI:10.1124/jpet.113.208223 |
|
[65] |
陈红, 王小超, 陶丽菊, 等. 雷公藤多苷联合泼尼松治疗类风湿关节炎肺间质病变的临床疗效[J]. 世界中医药, 2020, 15(4): 586-589, 594. CHEN H, WANG X C, TAO L J, et al. Analysis of clinical efficacy of Tripterygium wilfordii glycosides combined with prednisone in the treatment of rheumatoid arthritis with in-terstitial lung disease[J]. World Chinese Medicine, 2020, 15(4): 586-589, 594. DOI:10.3969/j.issn.1673-7202.2020.04.023 |
|
[66] | |
|
[67] |
陈宏, 张伟, 郭建波, 等. 地龙提取物通过抑制TGF-β1信号通路发挥抗肺纤维化作用研究[J]. 陕西中医, 2021, 42(4): 427-429. CHEN H, ZHANG W, GUO J B, et al. Analysis on the an-tifibrotic effect of earthworm extract by inhibiting TGF-β1 signaling pathway[J]. Shaanxi Journal of Traditional Chinese Medicine, 2021, 42(4): 427-429. DOI:10.3969/j.issn.1000-7369.2021.04.005 |
|
[68] |
张兴, 陈麒, 张一乐, 等. 生地提取物对肺纤维化大鼠血气分析影响及抗纤维化机制研究[J]. 云南中医学院学报, 2019, 42(01): 19-23. ZHANG X, CHEN Q, ZHANG Y L, et al. Study on the effect of Shengdi extract on blood gas analysis and anti -fibrosis mechanism of pulmonary fibrosis rats[J]. Journal of Yunnan University of Traditional Chinese Medicine, 2019, 42(01): 19-23. |
|
[69] |
栾智华, 张东坡, 刘必旺, 等. 黄芪甲苷对肺纤维化小鼠VEGF/VEGFR2信号通路的影响[J]. 时珍国医国药, 2019, 30(7): 1611-1613. LUAN Z H, ZHANG D P, LIU B W, et al. Effect of Astragaloside Ⅳ on VEGF/VEGFR2 Signal Pathway in Mice with Pul-monary Fibrosis[J]. Lishizhen Medicine and Materia Medica Research, 2019, 30(7): 1611-1613. |
|
[70] |
陈晓云, 苏励, 顾军花, 等. 活血化瘀法治疗类风湿性关节炎并肺间质病变[J]. 中华中医药杂志, 2010, 25(4): 629-631. CHEN X Y, SU L, GU J H, et al. Treatment of rheumatoid arthritis with interstitial lung disease by in removal stasis[J]. China Journal of Traditional Chinese Medicine and Phar-macy, 2010, 25(4): 629-631. |
|
[71] |
陈湘君, 顾军花, 茅建春, 等. 陈湘君教授治疗类风湿关节炎并发间质性肺炎经验应用总结[C]. 黄山: 中华中医药学会第十六届全国风湿病学术大会, 2012. CEHN X J, GU J H, MAO J C, et al. Summary of Professor CHEN Xiangjun's experience in treating rheumatoid arthri-tis complicated with interstitial pneumonia[C]. proceedings of the 16th national rheumatism academic conference of the Chinese society of Chinese medicine, Huangshan, Anhui, China, 2012.
|
|
[72] |
蒋军艳, 郑聪, 刘柳, 等. 类风湿关节炎合并肺间质病变的中医研究进展[J]. 风湿病与关节炎, 2018, 7(9): 77-80. JIANG J Y, ZHENG C, LIU L, et al. Research progress of rheumatoid arthritis with interstitial lung disease in tradi-tional Chinese medicine[J]. Rheumatism and Arthritis, 2018, 7(9): 77-80. DOI:10.3969/j.issn.2095-4174.2018.09.020 |
|
[73] |
赵珊. 活血化纤汤治疗类风湿关节炎合并间质性肺炎的临床研究[D]. 南宁: 广西中医药大学, 2017. ZHAO S. Clinical research on Huoxue Huaxian Decoction in the treatment of rheumatoid arthritis complicated with in-terstitial pneumonia[D]. Nanning: Guangxi University of Chinese Medicine, 2017.
|
|